NORDHEALTH AS A-AKSJER
NORDH
ADDITIONAL REGULATED INFORMATION REQUIRED TO BE DISCLOSED UNDER THE LAWS OF A MEMBER STATE
Nordhealth AS: Amendment of performance-based options to executive management and key employees
Helsinki, Finland, 31 March 2026: A maximum of 7,217,260 performance-based options linked to the Company's shares under an incentive scheme (the "Options"), were granted to members of the Company's executive management and key employees, on 30 September 2025.
The board of Nordhealth AS (the "Company") has today approved to amend the strike price of all 7,217,260 of the granted options, from NOK 35.20 to NOK 30.00, under the following conditions:
· The start of the time-based vesting of the Options is reset to 31st March 2026, and the Options still vest quarterly over 4 years. · The price-based performance thresholds remain unchanged (no Options vest below 11% CAGR in the share price, with linear increase up to 25% CAGR). · New condition: No Options vest below a minimum threshold of NOK 40.00 share price. · No increases have been or will be made to participants' salaries or bonuses in 2026. · The Option agreement remains the same in all other conditions.
For further information, please contact:
Charles MacBain, CEO charles.macbain@nordhealth.com
Alexander Cram, CFO alexander.cram@nordhealth.com